Cite
HARVARD Citation
Tashkin, D. et al. (2016). Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet. 4 (9), pp. 708-719. [Online].